LCK and prostate cancer: In a nitroproteomic study, researchers found that lymphocyte-specific protein tyrosine kinase (LCK), a key factor involved in T-cell activation, is nitrated and subsequently inactivated by MDSC-derived reactive nitrogen species (RNS) in a mouse model of treatment-resistant prostate cancer (76).